StonvexLoading…
StonvexStonvexStonvexCore line items from LNSR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $51.66M | $45.96M | $35.72M | $29.44M |
Operating Income | $-24.58M | $-10.66M | $-12.23M | $-20.18M |
Net Income | $-34.28M | $-31.40M | $-14.38M | $-19.91M |
EPS (Diluted) | $-2.87 | $-2.73 | $-1.31 | $-1.96 |
Total Assets | $71.43M | $66.30M | $69.58M | $55.84M |
Total Liabilities | $83.67M | $47.65M | $22.41M | $13.86M |
Cash & Equivalents | $12.97M | $16.26M | $20.62M | $14.67M |
Free Cash Flow OCF − CapEx | $-14.91M | $-2.43M | $-9.89M | $-14.97M |
Shares Outstanding | 11.99M | 11.65M | 11.33M | 11.09M |